作为高通量合成和 DNA 测序的先驱者，Leproust 博士正在颠覆市场，以实现 DNA 应用的指数级增长，包括化学品/材料、诊断、治疗、食品和数字数据存储。2020 年，BIO 向她颁发了 Rosalind Franklin 领导奖。《外交政策》杂志将她评为 100 位全球领先思想家之一，而 Fast Company 则将她评为商界最具创造力的人物之一。加入 Twist Bioscience 之前，她曾在 Agilent Technologies 履任要职，期间曾设计出大获成功的 SureSelect 生产线，从而降低了测序成本，并阐明了数十种孟德尔疾病的机制。她还开发了寡核苷酸库合成技术，并启动和领导了团队的产品和业务拓展活动。Leproust 博士设计并开发了多个商业合成平台，用于简化微阵列芯片的生产制造过程。She serves on the Board of Directors of GeneDx and is a co-founder of Petri, an accelerator for start-ups at the forefront of engineering and biology. Leproust 博士发表过 30 多篇经过同行评议的论文，其中许多是关于合成 DNA 的应用，同时她还是多项专利的作者。她曾在休斯顿大学取得有机化学博士学位，并在里昂工业化学学院取得工业化学硕士学位。 

Patrick 此前在生物试剂、B2B 和定制制造企业有着良好表现，成功实现了销售额的高速增长。他拥有相关的技术背景，并且能够识别出客户未被满足的需求，因此适合领导我们的商务工作。Paddy 在加入 Twist Bioscience 之前任职于 Enzymatics（近期被 QIAGEN 收购），担任销售与市场副总裁，负责领导北美和欧洲的商务活动；他在任职期间实现了显著的顶线增长，并将业务范围延伸到了商务客户。加入 Enzymatics 之前，Paddy 曾任多个商务要职，包括 Agilent Technologies 的业务开发总监、Beckman Coulter Molecular Diagnostics 的产品开发总监以及 Invitrogen and GE Healthcare/Amersham International 产品开发部门的多个技术职位。此外，Paddy 博士目前还任职于 Lasergen 的科学顾问委员会，并且之前曾任职于 Enzymatics 的科学顾问委员会。他拥有南安普敦大学的核酸化学博士学位和赫瑞瓦特大学荣誉商学士学位。

Adam has deep financial acumen and strategic planning expertise across diverse businesses along with a track record of collaborating across teams to drive profitable growth. Prior to joining Twist, Adam served as chief financial officer of Eargo, Inc., where he was responsible for finance, accounting, investor relations, business operations, internal audit and information technology. During his tenure at Eargo, revenue increased more than 300% over the course of two years. Prior to Eargo, Adam was vice president, worldwide financial planning and analysis and business operations at Tesla, Inc. where he was responsible for worldwide pricing, forecasting, capital planning, development of internal controls, and optimization of business operations. Previously, Adam served as vice president, finance and chief financial officer, cardiovascular care at Cardinal Health as the finance leader for the worldwide Cordis Cardiovascular business. He held a series of roles of increasing responsibility at Johnson & Johnson, where he led the divestiture of Cordis to Cardinal Health. He held additional positions within Johnson & Johnson including controller of the diabetes franchise, manager of supply chain and quality finance and customer service finance. Adam holds an MBA from the University of Southern California, Marshall School of Business and a B.S. in chemical engineering from the University of California at Berkeley.

Nicole is a visionary sales leader with over 17 years of experience driving commercial success within NGS, synthetic biology, molecular diagnostics and RNA therapeutics. She has a proven track record of building and coaching high-performing sales teams at local, national and global levels, and implementing innovative sales methodologies to meet evolving customer needs. Since joining Twist in 2020, Nicole has consistently delivered high growth sales across various vertical markets, serving in escalating positions within the commercial team. She was appointed SVP of Sales and Support in October 2024.

Before Twist Bioscience, Nicole held multiple leadership roles within the North America Custom Solutions & OEM sales teams at QIAGEN. During her tenure at QIAGEN, she successfully led the North American sales teams to achieve more than double team sales in 3 years and was recognized as a QIAGEN President's Circle Award Winner. Previously, Nicole served in senior sales roles at Enzymatics (a QIAGEN company), where she expanded the Western Region by driving customer and revenue growth through new business opportunities. Prior to Enzymatics, Nicole held positions at Affymetrix and USB Corporation where she substantially increased revenue growth through strategic account management and business development.

Nicole holds a B.S. in Biochemistry from Colorado State University.

陈博士是一位战略思想家，他在识别、开发和发布 NGS、合成生物学和其他生命科学领域的创新产品方面有着丰富经验。Twist 成立后不久，他就加入了公司，主要负责合成生物学和 NGS 产品系列的开发。陈博士构思并实施了包含对 SARS-CoV-2 和其他传染病的合成控制在内的全新 NGS 产品线，开发了基因合成和 NGS 靶向富集生物化学、工作流、试剂盒和基础设施，并联合硬件、软件和硅等领域的工程师们共同构建了公司的原型 DNA 合成器，为 Twist 奠定了技术基础，实现了规模化生产。陈博士发表了众多经过同行评议的论文，并在寡核苷酸合成和合成寡核苷酸的应用领域拥有多项专利。他在威斯康星大学麦迪逊分校获得了化学博士学位，在中国北京大学获得了化学学士学位。 

Paula Green 是一位经验丰富的人力资源执行官，他在开发和使用有关提升领导力、赋能高效组织的高影响力人员战略、解决方案、流程和工具方面有着骄人业绩。加入 Twist Bioscience 之前，她曾担任 QIAGEN 公司的人力资源副总裁，并在并购重组和其他重大的企业交易中负责带领 50 名人力资源专家，为 4,000 名员工提供支持。她曾是 Operon Technologies（被 QIAGEN 收购）的人力资源经理，主要负责制定战略、监督所有员工的福利以及提供培训、招聘和留用项目。她还曾担任旧金山联邦住房贷款银行的人力资源顾问。Paula 拥有旧金山大学的组织行为学学士学位。 

Mike is a seasoned executive with experience leading startups, developing commercial software, researching biology and physics and working in fast-paced deep-tech businesses.

Before joining Twist, he co-founded and served as CEO of TeselaGen Biotechnology for a decade, where he spearheaded TeselaGen’s enterprise software platform, providing a comprehensive suite of tools for DNA design, assembly, management and experimental workflows to a range of biotech customers from startups to Fortune 50 companies. Prior to TeselaGen, he was a principal investigator and NIH Career Fellow at Stanford University where he explored the signaling pathways that govern the bacteria cell cycle through the development of an automated epifluorescence microscopy platform including both hardware and software for high-throughput, high-content genetic screens and subsequent data analysis. He also served as director of Stanford Functional Genomics, where he collaborated on the development of the first human and murine genome scale microarrays. Prior to Stanford, Mike served as vice president of software engineering at Neomorphic where he guided development of a laboratory information management system (LIMS) solution for the human genome project at Lawrence Berkeley National Laboratory. Before Neomorphic, he held a variety of escalating positions at HyperParallel and Massachusetts Institute of Technology. 

Mike holds a Ph.D. in Physics and a B. A. in both Math and Physics, both from the University of California, Irvine. He completed a postdoctoral fellowship at the Massachusetts Institute of Technology, Cambridge and conducted international studies in Maths at Trinity College, Dublin. He serves as an advisor to both government and private groups exploring the promise, limits and concerns around the field of synthetic biology.

Mark is experienced in improving manufacturing efficiency and driving revenue and margin through managing supply chain and operations, including planning, quality, procurement and logistics. Prior to joining Twist, Mark served as corporate senior vice president, operations, global supply chain at Excelitas Technologies Corporation where he established a global footprint, drove global supply chain optimization measures, enabled scale up and drove revenue growth. His responsibilities included global supply chain planning, global sourcing and procurement supply, internal supply, supply quality and logistics inbound and outbound movement of freight. Prior to Excelitas, Mark was director, global supply chain management and general manager of resale product operations at Bio-Rad, Inc., where he managed buy-sell products, which grew in revenue to $270 million, significantly improving profitability over his time in the role. He previously held leadership positions including vice president operations, global manufacturing, supply chain and logistics at Celerity Group; director, operations management at Solectron corporation; and senior supply chain operations manager at Apple Computer, Inc. Before joining industry, Mark served in the United States Marine Corps. He holds an MBA from National University and a B.S. in electrical and computer engineering from University of Illinois, Urbana-Champaign.

Bill 是一位经验丰富的企业家和硅工程专家。他曾是四家初创企业的创始人或首位员工，并为初创企业提供咨询。作为 Complete Genomics 的硬件工程副总裁，他主导建立了自己的测序技术，并交付了三代人类基因组芯片和测序仪。Bill 曾两次获得美国国防部高级研究计划局 (DARPA) 的数百万美元拨款，用于开发基于硅微机械加工的创新技术。Bill 的职业生涯横跨了研究、产品开发和半导体器件加工等领域。他拥有亚利桑那大学的光学科学博士学位和密歇根大学的电子科学硕士学位，并曾在劳伦斯利弗莫尔国家实验室担任物理学家。

作为一名在生物制药行业拥有超过 25 年经验的高级传播主管，Angela 擅于清晰的表达和一致的传播，这让她在主要利益相关者中获得了一定的知名度，并承担了整个公司的文化和传播方面的工作。在加入 Twist 之前，她有 20 年的咨询服务经验，与生物制药、医疗设备和诊断领域的客户合作创建了关键信息，从而实现与外部受众的有效沟通。在开始咨询服务之前，Angela 曾担任 Exelixis 公司的投资者关系和企业传播部主管。她也在 Russell-Welsh 公司（一家精品医疗通信公司）工作了数年，期间与各种公共和私人客户就广泛的通信服务进行过合作。她拥有华盛顿大学的细胞和分子生物学理学学士学位和商业营销文学学士学位。她目前担任国家慈善联盟当地分会的临时副总裁。

Dennis Cho is a seasoned in-house business attorney with a proven track record of agile strategic guidance and practical problem solving. Prior to Twist, he served as assistant general counsel at CytomX Therapeutics, where he was department head for all deals and contracts as well as day-to-day lead on compliance and numerous other legal subject matters. Prior to CytomX, Mr. Cho was the lead transactional attorney on antibody-related licenses and collaborations, major commercial agreements, and combination trials at Seattle Genetics. Before that, he spent nine years at Celgene as the lead West Coast attorney supervising over 100 business transactions, including in- and out- licenses, options, collaborations and M&A agreements, and held primary legal responsibility for Celgene’s alliances, equity investments and “big data” machine learning initiative. Prior to Celgene, Mr. Cho served as general counsel for four private and public companies. He earned his J.D. and a B.A. in Molecular Cell Biology (Genetics) from University of California, Berkeley.